Delivery Order 36F79720D0148-36C24525N0983
Award Date
9/11/25
Potential Completion Date
9/12/25
Potential Value
$10K
Federal Agency
Veterans Integrated Service Network 5
Awardee
Harmony Biosciences LLC
Ultimate Awardee
Not listed
NAICS Category
325412 - Pharmaceutical Preparation Manufacturing
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Pittsburgh, PA 15275, USA
Solicitation Procedures
Multiple Award, Fair Opportunity
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a firm fixed-price delivery order awarded by the U.S. Department of Veterans Affairs (VA) to Harmony Biosciences LLC, a for-profit pharmaceutical company, for the supply of WAKIX 17.8 mg tablets. The contract, valued at $10,418.14, is issued under the VA's Pharmaceuticals and Drugs (FSS-61-IB) Federal Supply Schedule and supports the provision of narcolepsy treatment medications to VA healthcare facilities nationwide. Harmony Biosciences LLC holds a $25 million Blanket Purchase Agreement...
This is a firm fixed-price delivery order awarded by the Department of Veterans Affairs (VA) to Harmony Biosciences LLC, a for-profit pharmaceutical company. The $702,527.44 contract is for the delivery of WAKIX 17.8 mg tablets and is issued under the VA's Pharmaceuticals and Drugs (FSS-61-IB) Federal Supply Schedule. Harmony Biosciences specializes in medications for rare neurological diseases and sleep disorders, with WAKIX being used to treat excessive daytime sleepiness and cataplexy in...
This is a firm fixed-price delivery order awarded by the U.S. Department of Veterans Affairs (VA) to Harmony Biosciences LLC, a for-profit pharmaceutical company. The $10,418.14 contract is for the supply of WAKIX 17.8 mg, a medication used to treat excessive daytime sleepiness and cataplexy in adult narcolepsy patients. The contract is issued under the VA's Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB) and has an ultimate completion date of August 6, 2025. No set-aside...
This is a firm fixed-price delivery order awarded by the U.S. Department of Veterans Affairs (VA) to Harmony Biosciences LLC, a pharmaceutical company, for the supply of WAKIX (pitolisant) 17.8 mg tablets. The contract has a ceiling value of $5,209.20 and a performance period ending on February 14, 2025. The order was placed against Harmony Biosciences' Federal Supply Schedule (FSS) contract for Pharmaceuticals and Drugs (FSS-61-IB). This indicates that Harmony Biosciences has a broader,...
This is a firm fixed price delivery order awarded by the Department of Veterans Affairs (VA) Veterans Health Administration to Harmony Biosciences LLC, a for-profit pharmaceutical manufacturer, for the supply of WAKIX 17.8 MG tablets. The order was placed against the VA's Pharmaceutical and Drugs Federal Supply Schedule (FSS-61-IB) and has a potential value of $10,170. The delivery location is in Pittsburgh, PA, and the order is to be completed by April 26, 2024. No set-aside provisions were...
This federal contract award is for the delivery of WAKIX 17.8 mg tablets to the Department of Veterans Affairs (VA) through a Firm Fixed Price Delivery Order under the Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB). The prime contractor is Harmony Biosciences LLC, a for-profit pharmaceutical company specializing in rare neurological diseases and sleep disorders, headquartered in Plymouth Meeting, Pennsylvania. The $10,418.14 contract has an ultimate completion date of June 18,...
This is a firm-fixed-price delivery order awarded by the U.S. Department of Veterans Affairs (VA) to Harmony Biosciences LLC, a pharmaceutical company, to provide WAKIX 17.8 mg tablets. The order, valued at $5,085.00, is issued against Harmony Biosciences' General Services Administration (GSA) Pharmaceutical and Drugs Federal Supply Schedule (FSS-61-IB) contract. Harmony Biosciences has a $5 million Blanket Purchase Agreement with the VA National Acquisition Center to supply WAKIX, as well as...
This is a federal contract award from the Department of Veterans Affairs (VA) to Harmony Biosciences LLC, a pharmaceutical company that specializes in medications for rare neurological diseases and sleep disorders. The contract is a Delivery Order under the VA's Federal Supply Schedule (FSS-61-IB) for Pharmaceuticals and Drugs, with a ceiling value of $10,418.14. The contract is for the supply of WAKIX 17.8 mg, a medication used to treat excessive daytime sleepiness and cataplexy in adult...
The U.S. Department of Veterans Affairs (VA) awarded a $5,085.12 firm fixed price delivery order to Harmony Biosciences LLC, a pharmaceutical manufacturer, to provide WAKIX 17.8 MG tablets. This order is issued against Harmony Biosciences' General Services Administration (GSA) Federal Supply Schedule (FSS) contract for Pharmaceuticals and Drugs (FSS-61-IB). The delivery order has a completion date of September 27, 2024. No set-aside designation was applied to this procurement. Harmony...
This is a firm-fixed-price delivery order from the U.S. Department of Veterans Affairs (VA) Veterans Health Administration to Harmony Biosciences LLC for the prescription drug WAKIX (pitolisant). The order is valued at $5,085.00 and is being placed against Harmony Biosciences' General Services Administration (GSA) Federal Supply Schedule (FSS) contract for Pharmaceuticals and Drugs (FSS-61-IB). Harmony Biosciences, a for-profit pharmaceutical company specializing in rare neurological diseases...